Trial
NCT02271295
Impact on Morbidity and Mortality of Prophylactic Dosing of Low Molecular Heparin in Child-Pugh B Cirrhotic Patients
Phase IIISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
—
Condition
Cirrhosis
Intervention
Enoxaparine
Why stopped
Premature discontinuation of inclusions by the sponsor for low inclusion
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-27